Polycystic Ovary Syndrome in Salvador, Brazil: A Prevalence Study in Primary Healthcare

    January 2012 in “ Reproductive Biology and Endocrinology ”
    Lígia Gabrielli, Estela M. L. Aquino
    Image of study
    TLDR About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.
    The study conducted in Salvador, Brazil, with a sample of 859 women, found that the prevalence of Polycystic Ovary Syndrome (PCOS) was 8.5% using the Rotterdam criteria. Women with PCOS were generally younger, taller, had fewer children, were better educated, and had higher total testosterone levels and a higher LH/FSH ratio compared to those without PCOS. The study also noted the difficulty in diagnosing hirsutism and acne due to cultural and ethnic influences on body image perceptions. This research was significant as it was the first to estimate the prevalence of PCOS in Brazil or South America and suggested that sociocultural factors should be considered in future PCOS research.
    Discuss this study in the Community →

    Research cited in this study

    11 / 11 results

    Related Community Posts Join

    6 / 21 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 1 year ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community Sugar and Hair loss connections

      in Research/Science  41 upvotes 5 months ago
      High sugar diets may worsen hair loss by increasing 5α-reductase activity and androgen levels, especially in women with PCOS. A low sugar diet might reduce scalp DHT levels, similar to finasteride, but genetics also significantly influence hair loss.

      community C’est terrible - at my wits end

      in Female  450 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

    Related Research

    4 / 4 results